Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 470

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 470
---
 area, especially with the increasing importance of environmental regulations. 259 Legal Matters The validity of the Company Shares to be issued in connection with the Business Combination will be passed upon by Ogier (Cayman) LLP and the material U.S. federal income tax consequences of the Business Combination will be passed upon by Greenberg Traurig, P.A. Experts The combined financial statements of OmnigenicsAI Corp as of June 30, 2024 and 2023, and for the years ended June 30, 2024 and 2023 included in this proxy statement/prospectus have been so included in reliance on the report (which contains an explanatory paragraph relating to OmnigenicsAI Corp’s ability to continue as a going concern as described in Note 1 to the combined financial statements) of Price Waterhouse & Co. S.R.L., an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. The financial statements of APx Acquisition Corp. I as of December31, 2024 and 2023 and for the years ended December31, 2024 and 2023 included in this proxy statement/prospectus and elsewhere in the registration statement have been so included in reliance upon the report of Marcum LLP, independent registered public accountants, which includes an explanatory paragraph as to the ability of APx Acquisition Corp. I to continue as a going concern, upon the authority of said firm as experts in accounting and auditing. 260 Where You Can Find More Information As a foreign private issuer, after the consummation of the Business Combination, the Company will be required to file its annual report on Form 20 -Fwith the SEC no later than four months following its fiscal year end. APx files annual, quarterly and current reports, proxy statements and other information with the SEC as required by the Exchange Act. You can read APx’s SEC filings, including this proxy statement/prospectus, over the Internet at the SEC’s website at http: // www.sec.gov. All documents subsequently filed by APx pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the date on which the special meeting is held, shall be deemed to be incorporated by reference into this proxy statement/prospectus. If you would like additional copies of this proxy statement/prospectus or if you have questions about the Business Combination or the proposals to be presented at the Special Meeting, you may request copies of this proxy statement